Clinical trials sponsored by Institut Curie

Phase breakdown

Conditions studied

Recruiting trials led by Institut Curie

• 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
  NCT06349512 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 6 locations
• COsegregation of VARiants in Panel of Genes
  NCT01689584 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 62 locations
• Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
  NCT06659705 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
  NCT06195709 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
  NCT06225505 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 13 locations
• Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
  NCT04424719 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
  NCT04790682 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.
  NCT05439005 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · 3 locations
• Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
  NCT05475366 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 7 locations
• Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)
  NCT07491380 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials is Institut Curie recruiting for?

Institut Curie is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.